Exploring the Prevalence and Components of Metabolic Syndrome in Sub-Saharan African Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis

Table 4

Pooled prevalence of metabolic syndrome component based on NCEP-ATP III 2004.

Author (year)	Prevalence of metabolic syndrome component
	Sample	Central obesity	Low-HDL-c	High-TG	Hypertension
Titty et al. [26] 2008	456	43.6	47.4	37.5	46.9
Titty [27] 2009	300	69.6	58.5	56.4	69.6
Unadike et al. [29] 2009	240	74.4	17.3	48.0	86.7
Ogbera et al. [32] 2011	201	75.0	59.0	19.0	64.0
Nsiah et al. [36] 2015	150	48.6	41.3	32.7	60.0
Osei-Yeboah et al. [41] 2017	162	48.2	23.5	16.7	66.7
Woyesa et al. [42] 2017	314	61.3	39.2	70.4	28.0
Tadewos et al. [43] 2017	270	40.7	47.0	68.1	28.1
Birarra and Gelayee [45] 2018	256	53.5	67.2	68.8	43.4
Biadgo et al. [44] 2018	159	43.4	32.7	62.3	55.4
Pooled prevalence (95% CI)		55.9 (47.6, 64.2)	43.3 (33.5, 53.2)	48.0 (35.2, 60.7)	54.8 (43.2, 66.4)

CI: confidence interval; HDL-c: high density lipoprotein cholesterol; TG: triglyceride; NCEP-ATP III: National Cholesterol Education Program-Adult Treatment Panel III.